As MedTech commercial models evolve beyond traditional equipment sales, customers are increasingly evaluating long-term partnerships rather than standalone products. This article explores how subscriptions, managed services and outcome-focused agreements are reshaping buying decisions and what suppliers must do to deliver value throughout the customer relationship.

Our key takeaways from RAPS Convergence 2026 highlight the growing importance of PMCF, real-world evidence and robust study design in an evolving MedTech regulatory landscape

Recently, Director Hazel Haskayne and Director Sebastian Newton attended the EBME Expo, one of the UK's leading events for healthcare technology and medical equipment professionals.

While much of the conference focused on clinical engineering, several themes emerged that highlight how healthcare technology, procurement and innovation are continuing to evolve across the NHS and wider healthcare sector.

 We recently ran an internal knowledge-sharing session on endpoints, something we address every day in our post market survey work. We took a step back to define their critical role in protocol and survey design, and how these feed into medical device evaluations and regulations.

DeviceTalks Boston 2026 brought together MedTech leaders, innovators, and investors to discuss the realities shaping medical device and technology development today. Kristy Beede, Research Director, and Nicole Levin, Associate Director, attended the conference, where the conversations reflected a sector that is becoming more connected, more data-driven, and increasingly focused on scalable, real‑world impact.

We are delighted to be attending DeviceTalks Boston from 27–28 May 2026. Kristy Beede, Research Director, and Nicole Levin, Associate Director, will be representing Purdie Pascoe at the event.

With 2026 marking the Regulatory Affairs Professionals Society’s 50th anniversary, the atmosphere felt especially energised. Between packed auditoriums, poster sessions, and many conversations, one thing became increasingly clear: post-market evidence generation is entering a far more mature and strategically important phase.

We are thrilled to announce that Marcus Torr, Head of Post Market Surveys at Purdie Pascoe, has been selected for the MedTech Leading Voice (MLV) list for a second year in a row. Marcus regularly shares his expertise at industry events and on LinkedIn. We are incredibly proud to see him featured in the prestigious MLV100 list. Don't miss his future insights by following him on LinkedIn.

We are delighted to be attending, sponsoring and presenting at the RAPS Euro Convergence from 5-8 April in Lisbon. Purdie Pascoe’s Post Market Survey experts Marcus Torr (Head of Post Market Surveys) Ellie Baker (Commercial Director) Alice Robertson (Research Manager) and Ruby Pogson Jones (Senior Research Executive ) are exhibiting on booth 31.

We are delighted to be attending the ACC Annual Conference from March 28–30 in New Orleans, Louisiana. Senior Research Executives Molly Hines and Supreet Kaur will be representing Purdie Pascoe at the event.

We are delighted to be attending the SAGES Annual Conference from March 25–28 in Tampa, Florida. Kristin Lovallo, US Research Director, will be representing Purdie Pascoe at the event.

The 2026 MedTech Clinical Network Conference, hosted by TT Life Sciences in Brussels, brought together clinical leaders from across Europe at a pivotal time for the MedTech sector. Rather than simply revisiting regulatory updates, this year’s discussions focused on a broader challenge: how organisations can navigate uncertainty, strengthen clinical strategy, and generate evidence that delivers both regulatory assurance and commercial value.

Find out how we used a staged qualitative approach to help our client understand the landscape of digital solutions in GI endotherapy with a focus on AI, data management (clinical and non-clinical), workflow, and supply management.

As part of compliance with the EU Medical Device Regulation (MDR), the manufacturer of a Class III guidewire needed to generate robust Post Market Clinical Follow-Up (PMCF) data to confirm ongoing safety and performance. The study was designed to evaluate two key endpoints: procedural success, and freedom from adverse events.

Attending this year’s RAPS Congress we were reminded of why we do what we do; at the heart of every conversation from regulatory reform to AI innovation there was one shared purpose: improving patients’ lives.

Are you attending the RAPS European Lifecycle Management Conference from 28-29 October? Purdie Pascoe’s Head of Post Market Surveys, Marcus Torr will be attending and presenting.

We are delighted to be attending MedDev Day from 13-14 October 2025 in Budapest. Purdie Pascoe’s Head of Post Market Surveys, Marcus Torr will be attending and presenting at the conference.

Our client, a market-leading provider of vascular surgery products for aortic and peripheral vascular disease, wanted to understand how they could better service interventional cardiologists (ICs) and their patients by understanding ICs’ preferences, perceptions, and influences and priorities.

We are delighted to be the exhibiting at the RAPS Convergence, 7-9 October 2025 in Pittsburgh, US. Purdie Pascoe’s Post Market Survey experts Ellie Baker, Commercial Director and Chris Webb Research Manager | RCC- MDR are exhibiting on Booth 817.

Find out how we provided our client with a clear and effective path forward to help launch their pre-filled syringes for subcutaneous immunoglobulin therapy, and how best to position themselves for widespread adoption.